CN108283622A - 一种缓释型利奈唑胺眼用药物及其制备方法 - Google Patents
一种缓释型利奈唑胺眼用药物及其制备方法 Download PDFInfo
- Publication number
- CN108283622A CN108283622A CN201810298176.8A CN201810298176A CN108283622A CN 108283622 A CN108283622 A CN 108283622A CN 201810298176 A CN201810298176 A CN 201810298176A CN 108283622 A CN108283622 A CN 108283622A
- Authority
- CN
- China
- Prior art keywords
- linezolid
- release
- eye
- slow
- polycarbophil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Inorganic Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810298176.8A CN108283622A (zh) | 2018-04-03 | 2018-04-03 | 一种缓释型利奈唑胺眼用药物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810298176.8A CN108283622A (zh) | 2018-04-03 | 2018-04-03 | 一种缓释型利奈唑胺眼用药物及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108283622A true CN108283622A (zh) | 2018-07-17 |
Family
ID=62834263
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810298176.8A Pending CN108283622A (zh) | 2018-04-03 | 2018-04-03 | 一种缓释型利奈唑胺眼用药物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108283622A (zh) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1545428A (zh) * | 2001-09-14 | 2004-11-10 | �������Ŷ���Լ��������˾ | 某些噁唑烷酮类例如Linezolid的全身给药用于眼部感染的治疗 |
CN101766628A (zh) * | 2010-01-20 | 2010-07-07 | 广东宏盈科技有限公司 | 一种眼科外用抗细菌感染药物 |
CN103140216A (zh) * | 2010-09-03 | 2013-06-05 | 诺瓦加利制药公司 | 用于治疗眼睛疾病的油包水型乳液 |
CN104490861A (zh) * | 2014-11-21 | 2015-04-08 | 三明欣茂药业有限公司 | 一种缓释型奈帕芬胺眼用制剂 |
CN105030839A (zh) * | 2015-07-08 | 2015-11-11 | 张绪迎 | 一种眼科外用抗细菌感染药物 |
CN105311641A (zh) * | 2014-07-30 | 2016-02-10 | 广东宏盈科技有限公司 | 一种缓释型西罗莫司眼用制剂及其制备方法 |
-
2018
- 2018-04-03 CN CN201810298176.8A patent/CN108283622A/zh active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1545428A (zh) * | 2001-09-14 | 2004-11-10 | �������Ŷ���Լ��������˾ | 某些噁唑烷酮类例如Linezolid的全身给药用于眼部感染的治疗 |
CN101766628A (zh) * | 2010-01-20 | 2010-07-07 | 广东宏盈科技有限公司 | 一种眼科外用抗细菌感染药物 |
CN103140216A (zh) * | 2010-09-03 | 2013-06-05 | 诺瓦加利制药公司 | 用于治疗眼睛疾病的油包水型乳液 |
CN105311641A (zh) * | 2014-07-30 | 2016-02-10 | 广东宏盈科技有限公司 | 一种缓释型西罗莫司眼用制剂及其制备方法 |
CN104490861A (zh) * | 2014-11-21 | 2015-04-08 | 三明欣茂药业有限公司 | 一种缓释型奈帕芬胺眼用制剂 |
CN105030839A (zh) * | 2015-07-08 | 2015-11-11 | 张绪迎 | 一种眼科外用抗细菌感染药物 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP4248971A2 (en) | Compositions and methods of using nintedanib for treating ocular diseases with abnormal neovascularization | |
CN101766628B (zh) | 一种眼科外用抗细菌感染药物 | |
CN104490861A (zh) | 一种缓释型奈帕芬胺眼用制剂 | |
CN101716214A (zh) | 含有蒲公英提取物的药物组合物及其新用途和制备方法 | |
CN113041210B (zh) | 一种秋水仙碱外用组合物 | |
WO2018153315A1 (zh) | 一种多奈哌齐半帕莫酸盐的粉针剂、包含其的组合物及它们的制备方法 | |
CN108210450A (zh) | 释药系统及包含其组成的阿奇霉素眼用制剂及制备方法 | |
CN108186639B (zh) | 一种盐酸奈康唑的药物组合物 | |
CN108283622A (zh) | 一种缓释型利奈唑胺眼用药物及其制备方法 | |
CN113797163B (zh) | 一种滴眼给药防治干性黄斑病变和视网膜光损伤的眼用制剂 | |
US20230364047A1 (en) | Use of ester group-containing aromatic propionamide compound in preparation of medicine for treating dry eye syndrome | |
AU2021260669B2 (en) | A formulation for treating ophthalmic conditions | |
CN110279652B (zh) | 一种治疗角膜炎的纳米乳凝胶滴眼剂及制备方法 | |
CN110812323B (zh) | 一种眼用组合物、其制备方法及用途 | |
CN108904562A (zh) | 一种眼用凝胶剂及其制备方法和应用 | |
US20200093858A1 (en) | Vaginal bioadhesive boric acid formulation and its preparation method | |
CN108403624A (zh) | 一种缓释型利奈唑胺眼用药物及其制备方法与应用 | |
CN105749260A (zh) | 一种盐酸溶菌酶阴道片及其制备方法和应用 | |
CN102793730B (zh) | 银杏达莫的药物组合物及其制备方法 | |
CN108992398A (zh) | 一种含富马酸卢帕他定的眼用凝胶剂及其制备方法 | |
CN104523575B (zh) | 一种盐酸羟苄唑眼用凝胶剂及其制备方法 | |
CN102078287B (zh) | 一种人工麝香的眼用凝胶剂及其制备方法 | |
CN108186705A (zh) | 一种抗炎的凝胶剂及其制备方法 | |
CN102512362B (zh) | 一种复方环丙沙星滴眼液的配方及制备方法 | |
EP4282401A1 (en) | Ophthalmic preparation administered by eye drops and used for preventing and treating dry macular degeneration and retinal light damage |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Tan Shangbin Inventor after: Wang Yandong Inventor after: Chen Yuming Inventor after: Huang Junjie Inventor after: Cui Ming Inventor before: Tan Shangbin Inventor before: Wang Zhijun Inventor before: Chen Yuming Inventor before: Huang Junjie Inventor before: Cui Ming |
|
CB03 | Change of inventor or designer information | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180717 |
|
RJ01 | Rejection of invention patent application after publication |